Medical research

Whose health matters? The diversity deficit in clinical trials

Most people are aware that the process of bringing new medical products to market is rigorous, complex and tightly regulated. Diagnostic tests, therapies and treatments all go through lengthy, expensive trials to make sure ...

Diseases, Conditions, Syndromes

Researchers decipher mechanisms of liver regeneration

Scientists from the Berlin Institute of Health at Charité (BIH) and Open Targets together with colleagues from the University of Cambridge, and Addenbrooke's Hospital in Cambridge, U.K., uncovered mechanisms driving regeneration ...

page 1 from 40